Document is current
Any future updates will be listed below
-
Authors
Topka, Marlene
Schneider, Marlieke
Zrenner, Christoph https://orcid.org/0000-0002-9595-6923
Belardinelli, Paolo https://orcid.org/0000-0002-9290-1804
Ziemann, Ulf https://orcid.org/0000-0001-8372-3615
Weiss, Daniel https://orcid.org/0000-0003-0447-7132
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (WE5375-1/3)
- License Information
-
More Information
Article History
Received: 10 January 2022
Accepted: 26 October 2022
First Online: 23 November 2022
Competing interests
: Marlene Topka, Marlieke Schneider, Paolo Belardinelli report no conflicts of interest. Christoph Zrenner reports stock ownership in a University of Tübingen spin-off start-up, sync2brain GmbH, commercializing real-time biosignal analysis hardware; Ulf Ziemann received grants from the German Ministry of Education and Research (BMBF), European Research Council (ERC), German Research Foundation (DFG), Janssen Pharmaceuticals NV and Takeda Pharmaceutical Company Ltd., and consulting fees from Bayer Vital GmbH, Pfizer GmbH, and CorTec GmbH, all not related to this work. Daniel Weiss received consulting fees, traveling, and research grants from the Abbott, Abbvie, Bial, Boston Scientific, Medtronic, Kyowa Kirin, Stadapharm, and research grants from the German Research Foundation (WE5375/1-3) and Michael J Fox Foundation.
